Alantolactone inhibits cell autophagy and promotes apoptosis via AP2M1 in acute lymphoblastic leukemia

BACKGROUND: Acute lymphoblastic leukemia (ALL) is an aggressive hematopoietic malignancy that is most commonly observed in children. Alantolactone (ALT) has been reported to exhibit anti-tumor activity in different types of cancer. The aim of the present study was to investigate the anti-tumor activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Ce, Lan, Wenjia, Wang, Zhenkun, Yang, Dongguang, Wei, Jia, Liu, Zhiyu, Teng, Yueqiu, Gu, Mengmeng, Yuan, Tian, Cao, Fenglin, Zhou, Jin, Li, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488238/
https://www.ncbi.nlm.nih.gov/pubmed/32943990
http://dx.doi.org/10.1186/s12935-020-01537-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488238/
https://www.ncbi.nlm.nih.gov/pubmed/32943990
http://dx.doi.org/10.1186/s12935-020-01537-9

Ejemplares similares